Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine

Clinical trial NCT01021293 · COMPLETED

Trial details

NCT number: NCT01021293
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Poliomyelitis Poliomyelitis Vaccines

Start date: 2009-11-28
Primary completion: 2010-07-05
Enrollment: 1101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.